文献速递结核与非结核分枝杆菌

潜伏性结核感染:美国结核病消除的最后前沿

Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
PubMed 文献 · Lancet Infect Dis · 2017-05-08

美国自1989年追求结核病消除,近二十年取得进展后病例率趋于平稳且远高于消除阈值。流行病学与模型均强调必须处理潜伏性结核感染才能继续推进消除。本文探讨后续步骤:建立监测登记、扩大高危人群靶向检测、推广短程治疗、社区与提供者参与及增加公共卫生人员,并需新工具如再激活风险检测和更短方案。

要点

  • 美国结核病病例率已趋平稳且远高于消除阈值,消除需聚焦潜伏性结核感染。
  • 需建立监测登记、扩大高危人群靶向检测与短程治疗、加强社区参与和公共卫生人员。
  • 开发再激活风险检测和更短潜伏感染治疗方案将极大助力消除工作。

核心结论

  • 美国结核病消除进展停滞,必须解决潜伏性结核感染才能进一步推进消除。

研究设计与样本

  • 本文为Personal View,基于流行病学数据与模型探讨美国结核病消除的后续步骤。

主要发现

  • 美国结核病病例率已趋于平稳且远高于消除阈值。
  • 流行病学数据与模型均强调处理潜伏性结核感染的必要性。
  • 当前检测与治疗有限,与估计的潜伏感染流行率相比需大规模新努力。

关键数值与推荐

  • 努力应包括监测登记、高危人群靶向检测扩大、短程治疗推广、社区与提供者参与及增加公共卫生人员。
  • 需开发更好指示再激活风险的检测和比现有更短的潜伏感染治疗方案。

临床怎么用

  • 临床应扩大高危人群潜伏性结核感染靶向检测并推广短程治疗。
  • 应参与社区 engagement 并配合公共卫生监测登记与人员配置。

局限性

  • 本文为Personal View,未报告原始研究样本量、效应值或统计检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since 1989, the USA has been pursuing the goal of tuberculosis elimination. After substantial progress during the past two decades, the rate of tuberculosis cases in the USA each year has now levelled off and remains well above the elimination threshold. Both epidemiological data and modelling underline the necessity of addressing latent tuberculosis infection if further progress is to be made in eliminating the disease. In this Personal View we explore next steps towards elimination. Given the estimated prevalence of latent tuberculosis infection, compared with the limited testing and treatment that currently occur, a major new effort is required. This effort should consist of a surveillance system or registry to monitor progress, scale-up of targeted testing for latent tuberculosis infection in at-risk populations, scale-up of short-course treatment regimens, engagement of affected communities and medical providers who serve those communities, and increased public health staffing for implementation and oversight. Such an effort would benefit greatly from the development of new tools, such as tests that better indicate reactivation risk, and even shorter latent tuberculosis infection treatment regimens than currently exist.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. LoBue PA, Mermin JH. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA. Lancet Infect Dis. 2017. PMID: 28495525. doi:10.1016/S1473-3099(17)30248-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。